Literature DB >> 25129434

Regulation of human genome expression and RNA splicing by human papillomavirus 16 E2 protein.

Elaine J Gauson1, Brad Windle2, Mary M Donaldson3, Maria M Caffarel4, Edward S Dornan3, Nicholas Coleman4, Pawel Herzyk5, Scott C Henderson6, Xu Wang7, Iain M Morgan8.   

Abstract

Human papillomavirus 16 (HPV16) is causative in human cancer. The E2 protein regulates transcription from and replication of the viral genome; the role of E2 in regulating the host genome has been less well studied. We have expressed HPV16 E2 (E2) stably in U2OS cells; these cells tolerate E2 expression well and gene expression analysis identified 74 genes showing differential expression specific to E2. Analysis of published gene expression data sets during cervical cancer progression identified 20 of the genes as being altered in a similar direction as the E2 specific genes. In addition, E2 altered the splicing of many genes implicated in cancer and cell motility. The E2 expressing cells showed no alteration in cell growth but were altered in cell motility, consistent with the E2 induced altered splicing predicted to affect this cellular function. The results present a model system for investigating E2 regulation of the host genome.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Affymetrix; Cervical cancer; E2; Exon-array; Head and neck cancer; Host genome; Papillomavirus; Regulation; Splicing; Transcription

Mesh:

Substances:

Year:  2014        PMID: 25129434      PMCID: PMC5584639          DOI: 10.1016/j.virol.2014.07.022

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  52 in total

1.  Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function.

Authors:  Michal-Ruth Schweiger; Jianxin You; Peter M Howley
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

2.  E2 proteins from high- and low-risk human papillomavirus types differ in their ability to bind p53 and induce apoptotic cell death.

Authors:  Joanna L Parish; Anna Kowalczyk; Hsin-Tien Chen; Geraldine E Roeder; Richard Sessions; Malcolm Buckle; Kevin Gaston
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

3.  Identification and analysis of papillomavirus E2 protein binding sites in the human genome.

Authors:  Liisi Võsa; Aleksander Sudakov; Maido Remm; Mart Ustav; Reet Kurg
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

4.  An interaction between human papillomavirus 16 E2 and TopBP1 is required for optimum viral DNA replication and episomal genome establishment.

Authors:  Mary M Donaldson; Lorna J Mackintosh; Jason M Bodily; Edward S Dornan; Laimonis A Laimins; Iain M Morgan
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

Review 5.  The faces and friends of RhoGDI2.

Authors:  Erin M Griner; Dan Theodorescu
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

Review 6.  Exploiting epigenetic vulnerabilities for cancer therapeutics.

Authors:  Barbara Mair; Stefan Kubicek; Sebastian M B Nijman
Journal:  Trends Pharmacol Sci       Date:  2014-02-12       Impact factor: 14.819

Review 7.  Papillomaviruses in the causation of human cancers - a brief historical account.

Authors:  Harald zur Hausen
Journal:  Virology       Date:  2009-01-08       Impact factor: 3.616

8.  SF2/ASF binds the human papillomavirus type 16 late RNA control element and is regulated during differentiation of virus-infected epithelial cells.

Authors:  Maria G McPhillips; Thanaporn Veerapraditsin; Sarah A Cumming; Dimitra Karali; Steven G Milligan; Winifred Boner; Iain M Morgan; Sheila V Graham
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  The homolog of the five SH3-domain protein (HOFI/SH3PXD2B) regulates lamellipodia formation and cell spreading.

Authors:  Árpád Lányi; Mónika Baráth; Zalán Péterfi; Gábor Bogel; Anna Orient; Tünde Simon; Eniko Petrovszki; Katalin Kis-Tóth; Gábor Sirokmány; Éva Rajnavölgyi; Cox Terhorst; László Buday; Miklós Geiszt
Journal:  PLoS One       Date:  2011-08-23       Impact factor: 3.240

10.  Heterochromatin silencing of p53 target genes by a small viral protein.

Authors:  Conrado Soria; Fanny E Estermann; Kristen C Espantman; Clodagh C O'Shea
Journal:  Nature       Date:  2010-08-26       Impact factor: 49.962

View more
  19 in total

1.  Human Papillomavirus 16 E2 Regulates Keratinocyte Gene Expression Relevant to Cancer and the Viral Life Cycle.

Authors:  Michael R Evans; Claire D James; Molly L Bristol; Tara J Nulton; Xu Wang; Namsimar Kaur; Elizabeth A White; Brad Windle; Iain M Morgan
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

Review 2.  Human Papillomavirus E2 Protein: Linking Replication, Transcription, and RNA Processing.

Authors:  Sheila V Graham
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

Review 3.  The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.

Authors:  B Woodby; M Scott; J Bodily
Journal:  Prog Mol Biol Transl Sci       Date:  2016-10-11       Impact factor: 3.622

4.  EXPRESSION OF E8^E2 IS REQUIRED FOR WART FORMATION BY MOUSE PAPILLOMAVIRUS 1 IN VIVO.

Authors:  Frank Stubenrauch; Elke Straub; Katrin Klein; Daniela Kramer; Thomas Iftner; Margaret Wong; Richard B S Roden
Journal:  J Virol       Date:  2021-01-20       Impact factor: 5.103

5.  A Critical Role for p53 during the HPV16 Life Cycle.

Authors:  Christian T Fontan; Claire D James; Apurva T Prabhakar; Molly L Bristol; Raymonde Otoa; Xu Wang; Elmira Karimi; Pavithra Rajagopalan; Devraj Basu; Iain M Morgan
Journal:  Microbiol Spectr       Date:  2022-05-24

6.  Failure to interact with Brd4 alters the ability of HPV16 E2 to regulate host genome expression and cellular movement.

Authors:  Elaine J Gauson; Xu Wang; Edward S Dornan; Pawel Herzyk; Molly Bristol; Iain M Morgan
Journal:  Virus Res       Date:  2015-09-10       Impact factor: 3.303

7.  Human Papillomavirus E2 Regulates SRSF3 (SRp20) To Promote Capsid Protein Expression in Infected Differentiated Keratinocytes.

Authors:  T Klymenko; H Hernandez-Lopez; A I MacDonald; J M Bodily; S V Graham
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

Review 8.  RNA Binding Proteins that Control Human Papillomavirus Gene Expression.

Authors:  Naoko Kajitani; Stefan Schwartz
Journal:  Biomolecules       Date:  2015-05-05

Review 9.  Splicing and Polyadenylation of Human Papillomavirus Type 16 mRNAs.

Authors:  Chengjun Wu; Naoko Kajitani; Stefan Schwartz
Journal:  Int J Mol Sci       Date:  2017-02-09       Impact factor: 5.923

10.  RNA-Seq Analysis of Differentiated Keratinocytes Reveals a Massive Response to Late Events during Human Papillomavirus 16 Infection, Including Loss of Epithelial Barrier Function.

Authors:  T Klymenko; Q Gu; I Herbert; A Stevenson; V Iliev; G Watkins; C Pollock; R Bhatia; K Cuschieri; P Herzyk; D Gatherer; S V Graham
Journal:  J Virol       Date:  2017-11-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.